How were Inovalon's earnings last quarter?

Inovalon Holdings, Inc. (NASDAQ:INOV) announced its earnings results on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to analysts' expectations of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%.

What is Keith R. Dunleavy's approval rating as Inovalon's CEO?

410 employees have rated Inovalon Chief Executive Officer Keith R. Dunleavy on Glassdoor.com . Keith R. Dunleavy has an approval rating of 57% among the company's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of Inovalon own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD) , Pfizer (PFE) , Alibaba Group (BABA) , DexCom (DXCM) , NVIDIA (NVDA) , Digital Turbine (APPS) , PayPal (PYPL) , Block (SQ) , Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH) .

When did Inovalon IPO?

Inovalon (INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.

Who are Inovalon's major shareholders?

Inovalon's stock is owned by a number of retail and institutional investors. Top institutional shareholders include DHJJ Financial Advisors Ltd. (0.00%). View institutional ownership trends .

NASDAQ:INOV

Inovalon (INOV) Stock Price, News & Analysis

→ New crypto project uncovers 2,050% in 65 days (From InvestorPlace) (Ad)

Free INOV Stock Alerts

Notice: This company has been marked as potentially delisted and may not be actively trading.

Compare

Today's Range: $27.36
▼
$27.45
50-Day Range: $40.66
▼
$41.06
52-Week Range: $17.56
▼
$41.06

Volume: 5,692 shs
Average Volume: 720,587 shs
Market Capitalization: $4.25 billion

P/E Ratio: 80.47
Dividend Yield: N/A
Price Target: N/A

Stock Analysis Competitors Headlines Insider Trades Ownership Social Media Sustainability

Get Inovalon alerts:

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

About Inovalon Stock (NASDAQ:INOV)

Inovalon Holdings, Inc. engages in the development of cloud-based platforms for the healthcare industry. Its products include datasets, integration technologies, predictive analytics, and related services. The company was founded in 1998 and is headquartered in Bowie, MD.

Ad InvestorPlace

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

Just click here to sign up and be among the first to get it.

INOV Stock News Headlines

April 16, 2024 | finance.yahoo.com

FountainRx Selects Inovalon’s ScriptMed® Software To Enhance Patient Care and Scale Specialty and Infusion Pharmacy Services

April 5, 2024 | bizjournals.com

Maryland's 10 billionaires ranked by net worth, according to Forbes

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

March 18, 2024 | finance.yahoo.com

Inovalon Announces Converged Submissions To Support Health Plan Risk Adjustment Programs

March 5, 2024 | forbes.com

The Role Of Data At Every Step Of The Healthcare Journey

February 21, 2024 | finance.yahoo.com

Inovalon's VigiLanz Solution Ranked No. 1 by KLAS Research in Pharmacy Surveillance and Infection Control and Monitoring

February 15, 2024 | msn.com

Global Payments Earnings Transcript (NYSE:GPN)

February 7, 2024 | fortune.com

Exclusive: What Andreessen Horowitz’s Anish Acharya is looking for in consumer AI startups

April 19, 2024 | InvestorPlace (Ad)

New crypto project uncovers 2,050% in 65 days

During the event on Tuesday, April 23 at 10 am ET, I’ll be giving away the name and ticker symbol of crypto that could surge in price. I believe it will be the best performing crypto of 2024.

February 6, 2024 | msn.com

Inovalon buys clinical surveillance platform provider VigiLanz

January 24, 2024 | finance.yahoo.com

Clearsense Appoints Jason Rose as New Chief Executive Officer and Board Member

January 22, 2024 | finance.yahoo.com

Palmetto Pharm Selects Inovalon ScriptMed® To Improve Patient Outcomes and Streamline Operations

January 11, 2024 | finance.yahoo.com

NLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028, growing at a CAGR of 34.4%: Report by MarketsandMarkets™

January 9, 2024 | finance.yahoo.com

Michael Hasbany, Former Inovalon Executive, Joins Healthmine’s Advisory Board

January 8, 2024 | msn.com

2024 calendar dates: Easter, MLK Day, Thanksgiving and other key holiday dates to remember

January 4, 2024 | msn.com

Easter, MLK Day, Thanksgiving and other key dates to know for 2024 calendar

December 11, 2023 | finance.yahoo.com

Inovalon Applauded by Frost & Sullivan for Improving Healthcare Delivery, Patient Outcomes, and Data Security with Its Inovalon ONE® Platform

December 8, 2023 | finance.yahoo.com

Natural Language Processing (NLP) in Healthcare and Life Sciences Market to Hit $32.14 Billion by 2030: Coherent Market Insights

November 30, 2023 | benzinga.com

NLP in Healthcare & Life Sciences Market worth $11.8 billion by 2028 - Exclusive Report by MarketsandMarkets™

November 20, 2023 | finance.yahoo.com

Inovalon Introduces First-Ever Solution to Provide Health Plans Current Marketplace Quality Benchmarking Data Monthly

November 7, 2023 | tmcnet.com

HiLabs Grows Product Delivery Leadership With Sumeet Seth and Harsh Vardhan

November 7, 2023 | finance.yahoo.com

Inovalon Expands Schedule Management SaaS Solution to Include Management of Third-Party Agency Staff

November 2, 2023 | uk.finance.yahoo.com

Q3 2023 G1 Therapeutics Inc Earnings Call

October 30, 2023 | finance.yahoo.com

Inovalon Customers Achieve Higher Performance on CMS Medicare Advantage Health Plan Ratings

October 26, 2023 | benzinga.com

Healthcare IT Integration Market Is Anticipated To Amplify At A CAGR Of 12.4% Over 2023-2033 | We Market Research

October 24, 2023 | benzinga.com

Portnoy Law Investigates Enhanced Compensation for EngageSmart, Inc. Shareholders - ESMT

October 19, 2023 | finance.yahoo.com

eternalHealth Selects Inovalon Converged Cloud Platform to Make Quality Healthcare More Affordable

See More Headlines

Receive INOV Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Inovalon and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings: 7/28/2021
Today: 4/19/2024
Fiscal Year End: 12/31/2024

Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Sector: Computer and Technology
Industry: Data Processing & Preparation
Sub-Industry: N/A
Current Symbol: NASDAQ:INOV
CUSIP: N/A
CIK: 1619954
Web: www.inovalon.com
Phone: (301) 809-4000
Fax: 301-809-8060
Employees: 1,836
Year Founded: N/A

Profitability

EPS (Most Recent Fiscal Year): $0.34
Trailing P/E Ratio: 80.47
Forward P/E Ratio: 45.60
P/E Growth: 2.99
Net Income: $22.58 million
Net Margins: 6.73%
Pretax Margin: 5.86%
Return on Equity: 10.97%
Return on Assets: 4.10%

Debt

Debt-to-Equity Ratio: 1.17
Current Ratio: 2.40
Quick Ratio: 2.40

Sales & Book Value

Annual Sales: $667.52 million
Price / Sales: 6.36
Cash Flow: $0.82 per share
Price / Cash Flow: 33.35
Book Value: $4.94 per share
Price / Book: 5.54

Miscellaneous

Outstanding Shares: 155,246,000
Free Float: 78,011,000
Market Cap: $4.25 billion
Optionable: No Data
Beta: 0.53

7 Energy Stocks to Buy and Hold Forever

Do you expect the global demand for energy to shrink?! If not, it's time to take a look at how energy stocks can play a part in your portfolio.

Get This Free Report

Key Executives

Keith R. Dunleavy
Chairman & Chief Executive Officer
Eron S. Kelly
President
Jonathan R. Boldt
Chief Financial & Accounting Officer
Paige C. Kilian
Chief Medical Officer
Monica Keeneth
Chief Information Security Officer & VP

Key Competitors

View All Competitors

Institutional Ownership

View All Institutional Transactions

INOV Stock Analysis - Frequently Asked Questions

How were Inovalon's earnings last quarter?: Inovalon Holdings, Inc. (NASDAQ:INOV) announced its earnings results on Wednesday, July, 28th. The technology company reported $0.19 EPS for the quarter, beating analysts' consensus estimates of $0.17 by $0.02. The technology company earned $190.44 million during the quarter, compared to analysts' expectations of $183.89 million. Inovalon had a net margin of 6.73% and a trailing twelve-month return on equity of 10.97%.
What is Keith R. Dunleavy's approval rating as Inovalon's CEO?: 410 employees have rated Inovalon Chief Executive Officer Keith R. Dunleavy on Glassdoor.com. Keith R. Dunleavy has an approval rating of 57% among the company's employees. This puts Keith R. Dunleavy in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.
What other stocks do shareholders of Inovalon own?: Based on aggregate information from My MarketBeat watchlists, some companies that other Inovalon investors own include Advanced Micro Devices (AMD), Pfizer (PFE), Alibaba Group (BABA), DexCom (DXCM), NVIDIA (NVDA), Digital Turbine (APPS), PayPal (PYPL), Block (SQ), Taiwan Semiconductor Manufacturing (TSM) and Enphase Energy (ENPH).

When did Inovalon IPO?: Inovalon (INOV) raised $500 million in an initial public offering (IPO) on Thursday, February 12th 2015. The company issued 22,200,000 shares at $21.00-$24.00 per share. Goldman Sachs, Morgan Stanley, Citigroup, BofA Merrill Lynch and UBS Investment Bank served as the underwriters for the IPO and Baird, Piper Jaffray, Wells Fargo Securities and William Blair were co-managers.
Who are Inovalon's major shareholders?: Inovalon's stock is owned by a number of retail and institutional investors. Top institutional shareholders include DHJJ Financial Advisors Ltd. (0.00%).
View institutional ownership trends.

This page (NASDAQ:INOV) was last updated on 4/19/2024 by MarketBeat.com Staff

From Our Partners

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Inovalon (INOV) Stock Price, News & Analysis

About Inovalon Stock (NASDAQ:INOV)

INOV Stock News Headlines

Company Calendar

Industry, Sector and Symbol

Profitability

Debt

Sales & Book Value

Miscellaneous

Key Executives

Key Competitors

Institutional Ownership

INOV Stock Analysis - Frequently Asked Questions

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info